Clinical Performance of a Standardized Two-Step Drug Provocation Test Protocol after Retrospective Application of the EAACI/ENDA 2024 Risk Stratification: A Real-World Cohort Study.
- DOI
- 10.1159/iaa/adfag011
- Published
- 2026 Aug 31
- Container
- International archives of allergy and immunology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1159/iaa/adfag011,
title = {Clinical Performance of a Standardized Two-Step Drug Provocation Test Protocol after Retrospective Application of the EAACI/ENDA 2024 Risk Stratification: A Real-World Cohort Study.},
author = {Ramirez-Villamizar J and Espinosa-Silva DL and Olaya Hernández M and Ramírez Zuluaga LF and Serrano-Reyes CD},
year = {2026},
journal = {International archives of allergy and immunology},
doi = {10.1159/iaa/adfag011},
url = {https://doi.org/10.1159/iaa/adfag011}
}RIS
TY - JOUR TI - Clinical Performance of a Standardized Two-Step Drug Provocation Test Protocol after Retrospective Application of the EAACI/ENDA 2024 Risk Stratification: A Real-World Cohort Study. AU - Ramirez-Villamizar J AU - Espinosa-Silva DL AU - Olaya Hernández M AU - Ramírez Zuluaga LF AU - Serrano-Reyes CD PY - 2026 JO - International archives of allergy and immunology DO - 10.1159/iaa/adfag011 UR - https://doi.org/10.1159/iaa/adfag011 ER -
APA
J, R., DL, E., M, O. H., LF, R. Z., & CD, S. (2026). Clinical Performance of a Standardized Two-Step Drug Provocation Test Protocol after Retrospective Application of the EAACI/ENDA 2024 Risk Stratification: A Real-World Cohort Study.. International archives of allergy and immunology. https://doi.org/10.1159/iaa/adfag011
Source records
- pubmed · retrieved 2026-09-25T08:38:17.555Z